Grants for Public and State controlled institutions of higher education - Science and Technology

This funding opportunity provides financial support for research and evaluation projects aimed at improving youth justice systems, focusing on prosecution, defense delivery, reentry practices, and system reforms to better serve justice-involved youth.

This grant provides funding to non-profit organizations and educational institutions to implement projects that promote U.S.-Zambia cultural exchange and address key issues like mining, media transparency, and entrepreneurship.

This grant provides funding for research and development of advanced technologies in military communications, information operations, and cybersecurity, targeting organizations and researchers focused on enhancing defense capabilities.

This funding opportunity provides financial support to public and nonprofit organizations for managing fire science exchanges that deliver critical fire management information to stakeholders in six specific regions across the United States.

The FY24 PCRP Physician Research Award supports a mentored research experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research. The mentored physician is considered the Principal Investigator (PI) of the application. This award emphasizes equally the quality of the proposed research project and the career development of the PI, which should prepare physicians for careers in basic, population science, translational, or clinical prostate cancer research. All applications for the FY24 PCRP Physician Research Award are to be written by the PI, with appropriate direction from the mentor(s).Key elements of this award mechanism are as follows: Principal Investigator: Physicians with clinical duties and/or responsibilities who, at the application submission deadline, are either in the last year of an accredited graduate medical education program as a resident or fellow or within 5 years of having initiated a faculty appointment (including Instructor positions) are eligible to apply. The PI must demonstrate a commitment to a career as a physician-scientist and investigator at the forefront of prostate cancer research and clinical practice; however, the PI is not required to have previous prostate cancer research experience. The award is intended to provide protection of the PIs time for prostate cancer research. Applications are strongly encouraged to demonstrate protection of at least 20% of the PIs time for prostate cancer research, which is not required to be exclusive to this award but can include effort dedicated to other prostate cancer research projects. Mentor(s): This award requires the involvement of at least one designated mentor with an established research program in prostate cancer, as evidenced by recent publications, active funding, and successful mentorship. In addition, the mentor(s) must demonstrate a commitment to advancing the PIs career in prostate cancer research. Research Approach: Proposed research ideas are required to address one or more of the FY24 PCRP Overarching Challenges. The scientific rationale and experimental methodology should demonstrate in-depth analysis of the research problem presented. The feasibility of the research design and methods should be well defined, and a clear plan should be articulated as to how the proposed goals of the project can be achieved. The inclusion of preliminary data relevant to prostate cancer and the proposed project is encouraged but not required. Any preliminary data provided should be from the PI, mentor(s), or member(s) of the collaborating team. Additionally, required resources should be identified and supported through documentation. Research involving human subjects is permitted under this funding opportunity but is restricted to studies without clinical trials. Correlative studies associated with an existing clinical trial are particularly encouraged, provided they are determined to be no greater than minimal risk by the Institutional Review Board (IRB) of record and the USAMRDC Office of Human and Animal Research Oversight (OHARO), Office of Human Research Oversight. Researcher Development Plan: An individualized researcher development plan is required and should be prepared with appropriate guidance from the mentor(s). The researcher development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, and expertise that will enable the PI to successfully complete the proposed research project and foster the PIs development as an independent prostate cancer physician-scientist. An environment appropriate to the proposed mentoring and research project must be clearly described, although any deficiencies of resources and/or mentorship at the PIs institution can be mitigated through collaboration(s) with other institutions. If the PI will be utilizing resources at another institution to successfully complete the proposed project, then the PI is strongly encouraged to designate a co-mentor at the collaborating institution. Impact: The proposed research must address and provide a solution to one or more of the FY24 PCRP Overarching Challenges and ultimately should have the potential to make a significant impact on the programs mission of eliminating death and suffering from prostate cancer and enhancing the well-being of Service Members and their Families, Veterans, and all the patients and caregivers who are experiencing the impact of the disease.Investigators are strongly encouraged to incorporate the following components into their study design, where appropriate, in order to maximize the potential impact of the proposed research project: authentication of proposed cell lines; statistical rigor of preclinical animal experiments; and incorporation of experiments to assess clinical relevance and translatability of findings. Studies utilizing data that are derived from large patient studies that include long-term health records, biospecimen repositories, and pre-existing research and apply state-of-the-art genomic and/or proteomic analysis, bioinformatics, and/or mathematical models to such data are also encouraged. Investigators are highly encouraged to provide a letter of support indicating access to and the availability of any resources required to support the study.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 PCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more-effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs (VA), and other federal government agencies are highly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (https://www.nature.com/nature/ journal/v490/n7419/full/nature11556.html. While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies.Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 PCRP PRA Award should not exceed $750,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $4.80M to fund approximately four PCRP Physician Research Award applications. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This funding opportunity supports research and evaluation projects that address the needs of special populations in corrections, improve workforce management, and enhance correctional culture and safety, inviting a wide range of organizations to collaborate on innovative solutions.

This grant provides financial support to Indiana-based charitable organizations focused on transforming the industrial workforce through education and training in various technical and leadership fields.

This funding initiative provides financial support to regional partnerships of economic development organizations in Pennsylvania to enhance collaboration and deliver effective services that promote business growth and strengthen local economies.

To increase research capacity for NF, the NFRP is offering the NFRA. The intent of the NFRA is to provide a framework of intensive mentoring and iterative guidance with proposed research, national networking, collaborations, and a peer group of junior faculty (Scholars). The NFRP NFRA will bring together established NF investigators (one Director and one Deputy Director) and early-career independent investigators (Scholars) and their Career Guides to develop successful, highly productive NF scientists and clinicians that will conduct research with the aim of lessening the clinical impact of NF1, NF2, and schwannomatosis. The NFRA is a multi-institutional interactive virtual academy platform designed to offer support to NFRA Scholars with the goal to advance innovative, high impact NF research through a collaborative and career development environment.The functioning NFRA will consist of Scholars and their Career Guides (mentors) from different institutions, and an Academy Director and Deputy Director (see Figure 1 below). The Academy Director and Deputy Director will catalyze the growth and professional development of the Scholars in collaboration with their Career Guides, assess the progress of the Scholars, and facilitate communication and collaboration among all Academy members. The Career Guide is not required to be at the same institution as the Scholar; however, if the (primary) Career Guide is from a different institution, a secondary Career Guide at the Scholars institution is needed. The NFRA will afford Scholars opportunities to operate in a collegial, highly dynamic, and cutting-edge center to move early-career investigators towards positions as leaders in NF conducting impactful research.During this first phase of the academy, the NFRP is offering the FY24 NFRALA funding opportunity to solicit applications for an Academy Director and Deputy Director to lead the NFRA. The Academy Director and Deputy Director (referred to as Academy Leadership) must be established NF researchers and can be at different institutions. The Academy Leadership must demonstrate a strong record of mentoring and training early-career independent investigators, a commitment to leadership, the ability to articulate methods toward research collaborations, and the ability to objectively assess the progress of all Scholars in the NFRA. An objective of the NFRA leadership team is to establish the Academy structure in its first year and in subsequent years, conduct oversight of this activity. Other objectives will include execution of research that will engage NFRA FY25 Scholars (including subsequent-year Scholars), develop tools for Scholars to enable success, and provide opportunities to broaden their knowledge in NF disorders. The leadership team will identify and offer opportunities to network with other NFRP FY25 Early Investigator Research Award recipients (and subsequent year awardees) and NFRP FY25 New Investigator Award Early-Stage Investigator (NIA ESI) Award recipients (and subsequent year awardees). In the second stage of the academy, the NFRP anticipates release of funding opportunities for the Scholars who will conduct their research under the guidance of the NFRA leadership team.

The Idaho Department of Environmental Quality (DEQ) is offering 2025 Source Water Protection Grants to fund projects aimed at safeguarding public drinking water sources. These grants are designed to support activities that reduce the risk of contamination to drinking water, ensuring the long-term quality and safety of Idaho's water supply. The program aligns with the federal Safe Drinking Water Act, specifically Section 1452, which provides funding for source water assessment and protection efforts. By focusing on preventative measures and community-wide protection, the DEQ seeks to uphold its mission of protecting human health and the quality of the environment. The primary beneficiaries of these grants are public water systems, local government units, special districts, associations, nonprofit organizations, educational institutions, and tribes within Idaho. The impact goal is to improve the protection of one or more public water supply sources by reducing the threat of contaminants. Projects are expected to provide long-term benefits to source water quality, ultimately ensuring safe and reliable drinking water for communities across the state. The program prioritizes efforts that go beyond normal operational standards and existing infrastructure deficiencies, focusing on proactive and sustainable solutions. The program's priorities and focus areas are diverse, encompassing various strategies to protect source water. These include contaminant source identification through research, contaminant pathway removal such as the closure of abandoned wells, contaminant removal through hazardous waste collection and pollution prevention, and contaminant management via the implementation of best management practices and structures to divert contaminated runoff. Additionally, the grants support the restoration and conservation of ecological functions within source water protection areas, as well as education and information sharing campaigns to raise awareness. Security measures to protect physical extraction structures like wells, springs, and intake structures are also eligible, including fencing, gates, alarms, signs, cameras, locks, and lights directly related to source water area protection. Expected outcomes include a measurable reduction in the risk of drinking water contamination, improved source water quality, and enhanced long-term protection for public water supplies. The grants anticipate fostering a proactive approach to water resource management, leading to more resilient and secure drinking water systems. With up to $750,000 available for project funding in SFY2025, and a maximum request of $24,000 per project proposal, the program aims to support numerous initiatives that collectively contribute to a safer and more sustainable water future for Idaho. The emphasis on community public water supply systems and aquifer/watershed-wide protection efforts reflects a comprehensive strategic approach to water resource stewardship.

This grant provides funding for interdisciplinary research that explores how human behavior interacts with the built environment to improve disaster resilience and response to natural hazards.

This funding opportunity is designed to improve employment outcomes for individuals who are blind or have low vision through research, training, and technical assistance initiatives.

This funding opportunity provides up to $75,000 for researchers facing unique challenges in studying race, ethnicity, and immigration, enabling them to conduct specialized projects that require additional resources.

This funding opportunity supports U.S. institutions in conducting high-priority open-source research and technology development in Earth and space sciences, with potential participation from non-U.S. organizations under specific conditions.

This funding opportunity is designed for research institutions within the Pacific Northwest Cooperative Ecosystem Studies Unit to investigate deep-sea volcanic systems and hydrothermal environments in the Aleutian Island Arc, enhancing understanding of submarine volcanism and its environmental impacts.

The FY 2023-2024 CRISI program, managed by the Federal Railroad Administration (FRA), is designed to fund projects that improve the safety, efficiency, and reliability of railroad infrastructure. The program is open to various applicants, including states, rail carriers, and local governments, and it focuses on a broad array of project types such as safety enhancements, congestion reductions, upgrades to short-line or regional railroads, and the development of new or substantially improved intercity passenger rail corridors. The total funding available for this opportunity is approximately $2.478 billion. The application deadline is set for May 28, 2024, at 11:59 PM EST. Projects must not only improve infrastructure but also enhance safety protocols, integrate innovative technology, and support economic vitality.

The "Ocean Exploration Fiscal Year 2025 Funding Opportunity" grant is aimed at funding projects that explore unknown or poorly understood areas of the ocean or maritime heritage, with a focus on advancing our understanding of the ocean, improving genetic libraries for deep-sea species, and enhancing the identification and documentation of significant maritime heritage resources.

This competition provides funding for individuals and organizations to develop innovative energy storage technologies that address unique challenges in underserved communities and extreme climates.

The Business Women’s Giving Circle (BWGC) of the Community Foundation for Northern Virginia awards grants to support innovative STEM opportunities for girls and young women in the region. Since 2014, the BWGC has awarded over $520,000 in grants, aligning with the Foundation's mission to foster positive community impact by supporting initiatives in Science, Technology, Engineering, and Math (STEM), Leadership, and Entrepreneurship. This grant program is a key part of the Foundation's strategic approach to investing in the future workforce and leadership within Northern Virginia. The target beneficiaries are girls and young women, from preschool through college-age, residing in Northern Virginia. Specifically, organizations providing services in Arlington, Fairfax, Loudoun, and Prince William counties, as well as the cities of Alexandria, Fairfax, Falls Church, Manassas, and Manassas Park, are eligible. The impact goal is to create measurable positive changes in the lives of these girls and young women by providing them with exciting and enriching experiences in STEM, leadership, and entrepreneurship, thereby contributing to their educational and career development. The BWGC grant cycle prioritizes nonprofit organizations and schools that offer STEM programs with an emphasis on innovative components such as entrepreneurship, leadership, or mentorship. Funding is considered for both existing and new programs that directly support these areas. Applications for general organizational support, capital improvements, endowments, or scholarship awards are not considered, highlighting the program's focus on direct program delivery and innovation. Expected outcomes include increased participation and engagement of girls and young women in STEM fields, enhanced leadership skills, and the development of entrepreneurial mindsets. Measurable results are demonstrated by the impact on over 3,500 girls and young women since 2014. The Foundation's theory of change posits that by investing in innovative STEM, leadership, and entrepreneurship programs for girls and young women, they will empower the next generation of leaders and innovators, contributing to the economic vitality and social well-being of Northern Virginia.

This funding opportunity provides financial support for a wide range of innovative research projects in computing and information science, aimed at advancing technology and promoting equitable access to computing education across various organizations and individuals nationwide.